W12-039: Administration of pimobendan to cats with chronic kidney disease
Mary Anna Labato, Brandi Gallagher, John Rush; Tufts University: $20,000
Chronic kidney disease (CKD) is one of the most common reasons that senior cats are presented to veterinarians. These investigators have administered pimobendan to cats with combined kidney and heart disease after the patients developed congestive heart failure. In some of these patients, a greater improvement in kidney values and clinical response than is typically noted occurred when they were treated with pimobendan. Pimobendan is an effective drug for management of heart failure in dogs and may support kidney function through improved heart function and improved blood supply to the kidneys. This drug is also given to cats with heart disease. This pilot study will assess the effect of administering pimobendan to cats that only have CKD compared with standard treatment methods.